Aerocrine Overview
Update this profile
Aerocrine General Information
Description
Developer of a monitoring device for inflammatory airway diseases. The company provides a device to monitor exhaled nitric oxide (NO) from patients with inflammatory airway diseases such as asthma to assess the levels of their ailment and predict exacerbations.
Contact Information
Want to dig into this profile?
We’ll help you find what you need
Learn more
Aerocrine Valuation & Funding
Deal Type
Date
Amount
Raised to Date
Post-Val
Status
Stage
5. Merger/Acquisition
18-Jun-2015
$201M
000.00
00000
Completed
Generating Revenue
4. Debt - General
30-Apr-2013
000.00
000.00
Completed
Generating Revenue
3. PIPE
03-May-2012
000.00
000.00
Completed
Generating Revenue
2. IPO
15-Jun-2007
$32.5M
$32.5M
00000
Completed
Generating Revenue
1. Early Stage VC
01-Jan-1999
Completed
Startup
To view Aerocrine’s complete valuation and funding history, request access »
Aerocrine Signals
Growth Rate
0.80%
Weekly Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial